A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and notch signaling
Open Access
- 1 January 2020
- journal article
- research article
- Published by The Company of Biologists in Biology Open
- Vol. 10 (2)
- https://doi.org/10.1242/bio.050211
Abstract
The development of three-dimensional cell culture techniques has allowed cancer researchers to study the stemness properties of cancer cells in in vitro culture. However, a method to grow PAX3-FOXO1 fusion-positive rhabdomyosarcoma (FP-RMS), an aggressive soft tissue sarcoma of childhood, has to date not been reported, hampering efforts to identify the dysregulated signaling pathways that underlie FP-RMS stemness. Here, we first examine the expression of canonical stem cell markers in human RMS tumors and cell lines. We then describe a method to grow FP-RMS cell lines as rhabdospheres and demonstrate that these spheres are enriched in expression of canonical stemness factors as well as Notch signaling components. Specifically, FP-RMS rhabdospheres have increased expression of SOX2, POU5F1 (OCT4), and NANOG, and several receptors and transcriptional regulators in the Notch signaling pathway. FP-RMS rhabdospheres also exhibit functional stemness characteristics including multipotency, increased tumorigenicity in vivo, and chemoresistance. This method provides a novel practical tool to support research into FP-RMS stemness and chemoresistance signaling mechanisms.Funding Information
- National Institutes of Health (K12 HD043494)
- V Foundation for Cancer Research
- St. Baldrick's Foundation
- Duke University
- Alex's Lemonade Stand Foundation for Childhood Cancer
- Hyundai Hope On Wheels
- ok
This publication has 40 references indexed in Scilit:
- PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk StratificationJournal of Clinical Oncology, 2012
- Inhibition of the Notch-Hey1 Axis Blocks Embryonal Rhabdomyosarcoma TumorigenesisClinical Cancer Research, 2011
- Sox2 maintains self renewal of tumor-initiating cells in osteosarcomasOncogene, 2011
- Histone Methyltransferase KMT1A Restrains Entry of Alveolar Rhabdomyosarcoma Cells into a Myogenic Differentiated StateCancer Research, 2011
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803Journal of Clinical Oncology, 2009
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005Cancer, 2009
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar RhabdomyosarcomaCancer Research, 2008
- Is CD133 a marker of metastatic colon cancer stem cells?JCI Insight, 2008
- CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumorsJCI Insight, 2008
- Three-dimensional culture models of normal and malignant breast epithelial cellsNature Methods, 2007